Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows

v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net loss $ (78,340) $ (108,118)
Impairment of Long-Lived Assets to be Disposed of   4,471
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 35,068 37,198
Stock-based compensation 22,564 23,744
Foreign currency transaction loss (gain) (1,413) 4,087
Share in net (profits) losses of associated companies 1,559 11,866
Unrealized Gain (Loss) on Investments 3,424 5,681
Acquisitions 1,553  
Deferred income taxes, net and uncertain tax positions 238 2,891
Other non-cash items, net 2,751 2,494
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net 18,480 (19,676)
Inventories 171 (752)
Other current assets and prepaid expenses 6,173 (3,512)
Other non-current assets 5,257 4,198
Accounts payable 550 (13,031)
Other current liabilities (2,926) (2,967)
Deferred revenues (7,819) 5,123
Other non-current liabilities (6,853) (7,609)
Net cash provided by (used in) operating activities 437 (53,912)
Cash flows from investing activities    
Cash paid for business combinations, net of cash acquired 0 (68,360)
Purchase of property and equipment (6,668) (8,816)
Investments in short-term bank deposits (90,000) (31,448)
Proceeds from sale of equity method investment 90,000 128,815
Purchase of intangible assets (1,486) (1,487)
Other investing activities (176) (1,585)
Payments to Acquire Long-Term Investments (8,845) (6,274)
Net cash used in investing activities (17,175) 10,845
Cash flows from financing activities    
Proceeds from exercise of stock options 153 10
Payment of contingent consideration (1,302) (906)
Other financing activities 33 (188)
Net cash provided by (used in) financing activities (1,116) (1,084)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (178) (1,703)
Net change in cash, cash equivalents and restricted cash (18,032) (45,854)
Cash, cash equivalents and restricted cash, beginning of year 82,864 150,686
Cash, cash equivalents and restricted cash, end of year 64,832 104,832
Non-cash investing and financing activities:    
Transfer of inventories to fixed assets 1,850 7,316
Transfer of fixed assets to inventories 4,829 118
Stock Issued During Period, Value, Employee Stock Purchase Plan 3,264 3,014
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability   2,794
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 63,956 104,563
Restricted cash included in other current assets 876 269
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total $ 64,832 $ 104,832